Report cover image

Human Single-Cell Multi-Omics Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 121 Pages
SKU # APRC20352873

Description

Summary

According to APO Research, The global Human Single-Cell Multi-Omics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Human Single-Cell Multi-Omics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Single-Cell Multi-Omics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Single-Cell Multi-Omics.
The Human Single-Cell Multi-Omics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Single-Cell Multi-Omics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Human Single-Cell Multi-Omics Segment by Company

10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio
Human Single-Cell Multi-Omics Segment by Type

Single-Cell Proteomics
Single-Cell Genomics
Single-Cell Transcriptomics
Human Single-Cell Multi-Omics Segment by Application

Synthetic Biology
Clinical Research
Translational Research
Human Single-Cell Multi-Omics Segment by Application

Synthetic Biology
Clinical Research
Translational Research
Human Single-Cell Multi-Omics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Single-Cell Multi-Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Single-Cell Multi-Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Single-Cell Multi-Omics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Human Single-Cell Multi-Omics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

121 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Human Single-Cell Multi-Omics by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Single-Cell Proteomics
2.2.3 Single-Cell Genomics
2.2.4 Single-Cell Transcriptomics
2.3 Human Single-Cell Multi-Omics by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Synthetic Biology
2.3.3 Clinical Research
2.3.4 Translational Research
2.4 Assumptions and Limitations
3 Human Single-Cell Multi-Omics Breakdown Data by Type
3.1 Global Human Single-Cell Multi-Omics Historic Market Size by Type (2020-2025)
3.2 Global Human Single-Cell Multi-Omics Forecasted Market Size by Type (2026-2031)
4 Human Single-Cell Multi-Omics Breakdown Data by Application
4.1 Global Human Single-Cell Multi-Omics Historic Market Size by Application (2020-2025)
4.2 Global Human Single-Cell Multi-Omics Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Human Single-Cell Multi-Omics Market Perspective (2020-2031)
5.2 Global Human Single-Cell Multi-Omics Growth Trends by Region
5.2.1 Global Human Single-Cell Multi-Omics Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Human Single-Cell Multi-Omics Historic Market Size by Region (2020-2025)
5.2.3 Human Single-Cell Multi-Omics Forecasted Market Size by Region (2026-2031)
5.3 Human Single-Cell Multi-Omics Market Dynamics
5.3.1 Human Single-Cell Multi-Omics Industry Trends
5.3.2 Human Single-Cell Multi-Omics Market Drivers
5.3.3 Human Single-Cell Multi-Omics Market Challenges
5.3.4 Human Single-Cell Multi-Omics Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Human Single-Cell Multi-Omics Players by Revenue
6.1.1 Global Top Human Single-Cell Multi-Omics Players by Revenue (2020-2025)
6.1.2 Global Human Single-Cell Multi-Omics Revenue Market Share by Players (2020-2025)
6.2 Global Human Single-Cell Multi-Omics Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Human Single-Cell Multi-Omics Head Office and Area Served
6.4 Global Human Single-Cell Multi-Omics Players, Product Type & Application
6.5 Global Human Single-Cell Multi-Omics Manufacturers Established Date
6.6 Global Human Single-Cell Multi-Omics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Human Single-Cell Multi-Omics Market Size (2020-2031)
7.2 North America Human Single-Cell Multi-Omics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Human Single-Cell Multi-Omics Market Size by Country (2020-2025)
7.4 North America Human Single-Cell Multi-Omics Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Human Single-Cell Multi-Omics Market Size (2020-2031)
8.2 Europe Human Single-Cell Multi-Omics Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Human Single-Cell Multi-Omics Market Size by Country (2020-2025)
8.4 Europe Human Single-Cell Multi-Omics Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Human Single-Cell Multi-Omics Market Size (2020-2031)
9.2 Asia-Pacific Human Single-Cell Multi-Omics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Country (2020-2025)
9.4 Asia-Pacific Human Single-Cell Multi-Omics Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Human Single-Cell Multi-Omics Market Size (2020-2031)
10.2 South America Human Single-Cell Multi-Omics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Human Single-Cell Multi-Omics Market Size by Country (2020-2025)
10.4 South America Human Single-Cell Multi-Omics Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Human Single-Cell Multi-Omics Market Size (2020-2031)
11.2 Middle East & Africa Human Single-Cell Multi-Omics Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2020-2025)
11.4 Middle East & Africa Human Single-Cell Multi-Omics Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 10x Genomics
12.1.1 10x Genomics Company Information
12.1.2 10x Genomics Business Overview
12.1.3 10x Genomics Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.1.4 10x Genomics Human Single-Cell Multi-Omics Product Portfolio
12.1.5 10x Genomics Recent Developments
12.2 1CellBio
12.2.1 1CellBio Company Information
12.2.2 1CellBio Business Overview
12.2.3 1CellBio Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.2.4 1CellBio Human Single-Cell Multi-Omics Product Portfolio
12.2.5 1CellBio Recent Developments
12.3 BGI Genomics
12.3.1 BGI Genomics Company Information
12.3.2 BGI Genomics Business Overview
12.3.3 BGI Genomics Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.3.4 BGI Genomics Human Single-Cell Multi-Omics Product Portfolio
12.3.5 BGI Genomics Recent Developments
12.4 Bio-Rad Laboratories
12.4.1 Bio-Rad Laboratories Company Information
12.4.2 Bio-Rad Laboratories Business Overview
12.4.3 Bio-Rad Laboratories Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.4.4 Bio-Rad Laboratories Human Single-Cell Multi-Omics Product Portfolio
12.4.5 Bio-Rad Laboratories Recent Developments
12.5 Celsee
12.5.1 Celsee Company Information
12.5.2 Celsee Business Overview
12.5.3 Celsee Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.5.4 Celsee Human Single-Cell Multi-Omics Product Portfolio
12.5.5 Celsee Recent Developments
12.6 Fluidigm Corporation
12.6.1 Fluidigm Corporation Company Information
12.6.2 Fluidigm Corporation Business Overview
12.6.3 Fluidigm Corporation Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.6.4 Fluidigm Corporation Human Single-Cell Multi-Omics Product Portfolio
12.6.5 Fluidigm Corporation Recent Developments
12.7 Fluxion Biosciences
12.7.1 Fluxion Biosciences Company Information
12.7.2 Fluxion Biosciences Business Overview
12.7.3 Fluxion Biosciences Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.7.4 Fluxion Biosciences Human Single-Cell Multi-Omics Product Portfolio
12.7.5 Fluxion Biosciences Recent Developments
12.8 MissionBio
12.8.1 MissionBio Company Information
12.8.2 MissionBio Business Overview
12.8.3 MissionBio Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.8.4 MissionBio Human Single-Cell Multi-Omics Product Portfolio
12.8.5 MissionBio Recent Developments
12.9 NanoString Technologies
12.9.1 NanoString Technologies Company Information
12.9.2 NanoString Technologies Business Overview
12.9.3 NanoString Technologies Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.9.4 NanoString Technologies Human Single-Cell Multi-Omics Product Portfolio
12.9.5 NanoString Technologies Recent Developments
12.10 Takara Bio
12.10.1 Takara Bio Company Information
12.10.2 Takara Bio Business Overview
12.10.3 Takara Bio Revenue in Human Single-Cell Multi-Omics Business (2020-2025)
12.10.4 Takara Bio Human Single-Cell Multi-Omics Product Portfolio
12.10.5 Takara Bio Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.